Adequan® Canine (polysulfated glycosaminoglycan) is the only product that safely attacks canine arthritis four ways:
Adequan® Canine (polysulfated glycosaminoglycan) is not a nutraceutical. It is the only FDA-approved* disease-modifying osteoarthritis drug (DMOAD). No other drug combats canine arthritis to the degree of Adequan® Canine.
Several studies** have demonstrated the efficacy of Adequan® Canine in controlling signs of non-infectious degenerative and/or traumatic arthritis.
* NADA #141-038, Approved by FDA
** Source: Freedom of Information - NADA #141-038; Title: Controlled Field Trial
| 
opinion_lab.tpl
